A study led by World Bank economist Jishnu Das and published in Health Affairs on Monday examines the quality of primary care delivered by private and public health care providers in rural and urban India, a World Bank press release notes. The study found many providers do not have medical degrees; the quality of medical training is low; and less than half of providers provide correct diagnoses, according to the press release, which says the results show an “urgent need” to carefully measure the quality of care. “The study could help policymakers make evidence-based decisions,” the press release notes, adding, “In November, the government announced a five-year plan to triple health spending and improve the quality of health services” (12/3).
Private Sector Involvement
Seattle Times Examines Partnership Between Hutchinson Cancer Research Center, Uganda Cancer Institute
The Seattle Times examines a partnership between the Fred Hutchinson Cancer Research Center and the Uganda Cancer Institute (UCI). In 2008, “the two institutes formally agreed to collaborate on clinical care and research projects, and more recently a major building project at Uganda’s only cancer-research center,” the newspaper writes. Corey Casper, director of the UCI/Fred Hutchinson Research Center Cancer Alliance, “says [the partnership] has the potential to demonstrate ‘that you can do first-rate research that can alter the impact of cancer care in the developing world, and that the craft of oncology can be practiced as well in Africa as it is in the developed world, just like it is with HIV,'” according to the Seattle Times (Silberner, 12/16).
Olivier De Schutter, the U.N. special rapporteur on the right to food, writes in a Guardian opinion piece, “In order to support investment in agriculture, governments have … come to rely on private sector investment and development aid — and increasingly a partnership of the two,” and he notes “[t]he New Alliance for Food Security and Nutrition, proposed by [U.S. President] Barack Obama and the U.S. Agency for International Development and launched in May 2012, will draw more than $3 billion of private sector investment into food security plans in Africa.” He continues, “One potential danger of development aid, and particularly of private-led projects, is that the goals of poverty reduction and rural development can be relegated below the goal of raising food production.”
“Each year, the United States spends more than $1.5 billion feeding starving people overseas,” columnist Farah Stockman writes in a Boston Globe opinion piece. “But our charity comes with a catch: The food has to be bought in America, and much of it must be shipped on American ships,” she continues, adding, “Researchers estimate that buying food closer to where needy people are costs about half as much.” She continues, “We are the last donor country in the world to have these rules,” and writes, “At a time of budget cuts, you would think that one thing Republicans and Democrats could agree on would be making sure every tax dollar stretches as far as it can.” Stockman asks, “Why don’t we just change it?”
UNFPA and mobile phone company Nokia announced this week that the “company will donate the equivalent of 3,000 clean delivery kits to the fund,” according to an UNFPA press release. “The kits, designed and distributed by UNFPA, help ensure safe delivery of babies in humanitarian settings,” and are being provided as a result of the fund’s social media campaign “Safe Birth. Even Here.,” the press release states, adding, “The campaign, which reports on and tracks safe deliveries in refugee camps and emergencies around the globe, is active on Twitter, Facebook and Pinterest, and aims to raise awareness about maternal health and the challenges faced by expectant mothers in crisis settings” (12/4).
New Public-Private Partnership Will Allow Brazil To Produce Patented ARV For National Treatment Program
For the first time, Brazil in 2013 will enter into a new type of public-private partnership that allows the nation to produce a generic version of the antiretroviral (ARV) drug atazanavir sulphate, which will be under patent through its producer Bristol-Myers Squibb until 2017, Inter Press Service reports. Under the “productive development partnership,” Farmanguinhos, “a technical-scientific unit of the Oswaldo Cruz Foundation (Fiocruz) and the Health Ministry’s largest pharmaceutical laboratory,” will make the drug, one of 20 ARVs the government distributes at a cost of about $425 million annually, according to the news service.
Medecins Sans Frontieres (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the Mount Sinai School of Medicine this week are hosting a conference in New York, titled “Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations,” the Philadelphia Inquirer reports. In a video presentation, World Bank President Jim Yong Kim “told the conference … that the goal is to ‘lay the foundation of a health science that works for the poor,'” according to the newspaper. “That means innovative research on diseases and delivery systems geared to people in developing nations, not the more affluent ones, greater sharing of ideas, and support for developing nations so they can assist in the process from beginning to end,” the newspaper writes (Sell, 12/14).
The Guardian’s “Poverty Matters Blog” examines efforts to prevent and treat cervical cancer in sub-Saharan Africa, where “cervical cancer kills large numbers of women, many of whom are never diagnosed because local hospitals do not recognize the disease until it is too late.” However, “[a] very simple and cheap form of screening has begun to be introduced — and now there is the possibility of a vaccination program against the sexually transmitted human papilloma virus (HPV) that causes most cervical cancers,” the blog writes, noting a recent announcement by the GAVI Alliance that it plans to fund HPV immunization programs in several countries. According to the blog, “15 countries [are] asking to be considered,” and “Uganda and Rwanda have already been approved, although some ‘clarifications’ are required from the governments on how their programs will run.” The blog continues, “No one believes it will be easy to introduce the HPV vaccination in Africa, and there may be problems,” including issues with efficacy and cost (Boseley, 12/14).
Also In Global Health News: Malaria Vaccine; Brazil’s Progress Toward MDGs; Malnutrition In Guatemala; Treatments For Kala-Azar
PATH, Merck, NYU To Work Together On Development Of Vaccine To Keep Malaria Parasite From Entering Liver The PATH Malaria Vaccine Initiative (MVI), pharmaceutical company Merck and New York University’s Langone Medical Center on Tuesday announced they were collaborating “to develop a vaccine capable of preventing the malaria parasite from…
Also In Global Health News: Clinical Trial Participants Abroad; PMTCT Project In Malawi; Congo Polio Outbreak; Global Fund Zambia Grant; Women, Girls In Afghanistan
Lancet World Report Examines Protections In Place For Clinical Trial Participants Abroad Lancet World Report, in a follow-up on the revelations over the U.S.’s role in medical experiments conducted on Guatemalan prisoners in the 1940s writes: “A thorough review of the safeguards in place to protect modern human trial participants…